Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Hartej, Gill"'
Publikováno v:
Journal of Contemporary Issues in Education, Vol 18, Iss 2 (2023)
Externí odkaz:
https://doaj.org/article/92ed181c3546450199123c56f0eaa5f3
Autor:
Joshua Daniel Di Vincenzo, Liam O’Brien, Ira Jacobs, Muhammad Youshay Jawad, Felicia Ceban, Shakila Meshkat, Hartej Gill, Aniqa Tabassum, Lee Phan, Sebastian Badulescu, Joshua Daniel Rosenblat, Roger S. McIntyre, Rodrigo B. Mansur
Publikováno v:
Nutrients, Vol 15, Iss 7, p 1686 (2023)
Psychiatric and metabolic disorders are highly comorbid and the relationship between these disorders is bidirectional. The mechanisms underlying the association between psychiatric and metabolic disorders are presently unclear, which warrants investi
Externí odkaz:
https://doaj.org/article/1f9c1cb780c646adbcab743df2384bd3
Autor:
Felicia Ceban, Dana Kulzhabayeva, Nelson B. Rodrigues, Joshua D. Di Vincenzo, Hartej Gill, Mehala Subramaniapillai, Leanna M.W. Lui, Bing Cao, Rodrigo B. Mansur, Roger C. Ho, Matthew J. Burke, Taeho Greg Rhee, Joshua D. Rosenblat, Roger S. McIntyre
Publikováno v:
Brain, Behavior, and Immunity. 111:211-229
Autor:
Yazen Alnefeesi, Ashley Siegel, Leanna M. W. Lui, Kayla M. Teopiz, Roger C. M. Ho, Yena Lee, Flora Nasri, Hartej Gill, Kangguang Lin, Bing Cao, Joshua D. Rosenblat, Roger S. McIntyre
Publikováno v:
Frontiers in Psychiatry, Vol 11 (2021)
The prevalence and etiology of COVID-19's impact on brain health and cognitive function is poorly characterized. With mounting reports of delirium, systemic inflammation, and evidence of neurotropism, a statement on cognitive impairment among COVID-1
Externí odkaz:
https://doaj.org/article/7cde17d9b19f4465a201df0f44893830
Autor:
Hartej Gill, Jonathan M. Lieberman, Joshua D. DiVincenzo, Nelson B. Rodrigues, Rodrigo B. Mansur, Andrea McKenzie, Lee Phan, Joshua D. Rosenblat, Roger S. McIntyre
Publikováno v:
Current Treatment Options in Psychiatry. 9:331-345
Autor:
Niloufar Pouyan, Zahra Halvaei Khankahdani, Farnaz Younesi Sisi, Yena Lee, Joshua D. Rosenblat, Kayla M. Teopiz, Leanna M. W. Lui, Mehala Subramaniapillai, Kangguang Lin, Flora Nasri, Nelson Rodrigues, Hartej Gill, Orly Lipsitz, Bing Cao, Roger Ho, David Castle, Roger S. McIntyre
Publikováno v:
CNS Drugs. 36:1031-1047
Autor:
Yazen Alnefeesi, David Chen-Li, Ella Krane, Muhammad Youshay Jawad, Nelson B. Rodrigues, Felicia Ceban, Joshua D. Di Vincenzo, Shakila Meshkat, Roger C.M. Ho, Hartej Gill, Kayla M. Teopiz, Bing Cao, Yena Lee, Roger S. McIntyre, Joshua D. Rosenblat
Publikováno v:
Journal of Psychiatric Research. 151:693-709
Ketamine is a promising therapeutic option in treatment-resistant depression (TRD). The acute efficacy of ketamine in TRD has been demonstrated in replicated randomised-controlled trials (RCTs), but the generalizability of RCT data to real-world prac
Autor:
Karren Xiao, Emily S. Gillissie, Leanna M.W. Lui, Felicia Ceban, Kayla M. Teopiz, Hartej Gill, Bing Cao, Roger Ho, Joshua D. Rosenblat, Roger S. McIntyre
Publikováno v:
Journal of Affective Disorders. 304:66-77
Mental disorders are associated with immune dysregulation as measured by serum levels of biological markers of immunity. Adults with mental disorders have also been reported to have attenuated post vaccine immune response. The COVID-19 pandemic has i
Autor:
Sabine El-Halabi, Daniel H. Cooper, Danielle S. Cha, Joshua Daniel Rosenblat, Barjot Gill, Nelson B. Rodrigues, Orly Lipsitz, Roger S. McIntyre, Hartej Gill
Publikováno v:
Journal of Affective Disorders. 300:219-225
Background Extant literature has identified Major Depressive Disorder (MDD) as a comorbid disorder in individuals with seropositive human immunodeficiency disorder (HIV), and this may affect HIV-treatment efficacy. However, there is a paucity of lite
Autor:
Farhan Fancy, Nelson B. Rodrigues, Joshua D. Di Vincenzo, Edmond H. Chau, Rickinder Sethi, Muhammad I. Husain, Hartej Gill, Aniqa Tabassum, Andrea Mckenzie, Lee Phan, Roger S. McIntyre, Joshua D. Rosenblat
Publikováno v:
Bipolar disorders.
Clinical trials have demonstrated rapid antidepressant effects with intravenous (IV) ketamine for major depressive disorder, with relatively less research specifically for bipolar depression. Herein, we describe the real-world effectiveness of repeat